Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog

Chapman, W.L., jr; Hanson, W.L.; Alving, C.R.; Hendricks, L.D.

Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog

1984

Chapman, W.L., jr | Hanson, W.L. | Alving, C.R. | Hendricks, L.D.

Leishmania donovani, dogs (exper.), liposome-encapsulated meglumine antimoniate (LEMA) vs. unencapsulated meglumine antimoniate, LEMA was 700 times more efficacious than the encapsulated drug, liposomes can markedly reduce the drug dosage required for equivalent treatment of visceral leishmaniasis

Show more [+]

AGROVOC Keywords

animals antimony antiprotozoal agents dogs drug therapy leishmania leishmania donovani leishmaniasis meglumine pharmacology technique

Bibliographic information

Published in

American journal of veterinary research

Volume 45 Issue 5 Pagination 1028 - 1030 ISSN 0002-9645

Other Subjects

Drug effects; Treatment; Administration & dosage; Liposomes; Veterinary; Organometallic compounds; Dog diseases; Therapeutic use; Visceral; Treatment and control

Language

English

Type

Journal Article; Text

In AGRIS since: 2024-02-28

Format: MODS

Data Provider

This bibliographic record has been provided by National Agricultural Library

Discover this data provider's collection in AGRIS

Lookup at Google Scholar

If you notice any incorrect information relating to this record, please contact us at agris@fao.org